Literature DB >> 21924008

Health economic evaluations help inform payers of the best use of scarce health care resources.

Daria O'Reilly1, Kathryn Gaebel, Feng Xie, Jean-Eric Tarride, Ron Goeree.   

Abstract

OBJECTIVES: The number of new health technologies has risen over the past decade. These new technologies usually are more effective but they also cost more compared to existing ones. In a publicly funded health care system such as Canada, the aim is to maximize the health of the population within the resources available. As a result, it is unavoidable that choices and trade-offs have to be made because there will always be more treatment options than resources will allow (i.e., scarcity of resources) as well as alternative uses for those resources (i.e., opportunity costs). The objective of this paper is to provide an overview of economic evaluations and how these tools can be used to help inform payers of the best use of scarce health care resources. STUDY
DESIGN: This descriptive paper includes a summary of key consepts and definitions in economic appraisal and draws upon recently published papers as illustrations.
METHODS: Background on the necessity and role of economic evaluations is provided, followed by a description of the approaches for, and types of, economic evaluations. Two illustrative examples are used and some implications for rural, remote and circumpolar communities are discussed.
RESULTS: There are 2 main approaches for conducting an economic evaluation (trial- and model-based) and 3 types of evaluations which can be considered to inform payers of the best use of health care resources (cost-effectiveness, cost-utility and cost-benefit analyses).
CONCLUSIONS: Techniques of economic evaluation are useful tools and an important input into the decision-making process. Although these techniques have universal application, there are issues specific to rural, remote and circumpolar communities which can affect the results of economic appraisals.

Mesh:

Year:  2011        PMID: 21924008

Source DB:  PubMed          Journal:  Int J Circumpolar Health        ISSN: 1239-9736            Impact factor:   1.228


  4 in total

1.  Opportunity cost in the economic evaluation of da Vinci robotic assisted surgery.

Authors:  Fernando Fuertes-Guiró; Montserrat Girabent-Farrés; Eduardo Viteri-Velasco
Journal:  Eur J Health Econ       Date:  2015-03-06

2.  Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin.

Authors:  Antonio Pérez; Pedro Mezquita Raya; Antonio Ramírez de Arellano; Teresa Briones; Barnaby Hunt; William J Valentine
Journal:  Diabetes Ther       Date:  2015-03-06       Impact factor: 2.945

3.  Cost effectiveness of a controlled lifestyle intervention for pregnant women with obesity.

Authors:  Hanna Gyllensten; Karin Haby; Marie Berg; Åsa Premberg
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-21       Impact factor: 3.007

4.  The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians.

Authors:  Silvia Sommariva; Aureliano P Finch; Claudio Jommi
Journal:  Multidiscip Respir Med       Date:  2016-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.